Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C9H14N4O3.ClH |
| Molecular Weight | 262.693 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O
InChI
InChIKey=HIXYEIRACBUSON-FJXQXJEOSA-N
InChI=1S/C9H14N4O3.ClH/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6;/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16);1H/t7-;/m0./s1
| Molecular Formula | C9H14N4O3 |
| Molecular Weight | 226.2325 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Carnosine is a dipeptide composed of the amino acids beta-histidine and l-alanine. It is widely present in muscle and brain tissues. It possesses strong and specific antioxidant properties, protects against radiation damage, and promotes wound healing. The antioxidant mechanism of carnosine is attributed to its chelating effect against metal ions, superoxide dismutase (SOD)-like activity, ROS and free radicals scavenging ability. In addition, was shown, that carnosine significantly protects against TCA-induced liver carcinogenesis in rats, through its antioxidant, antinutritive, and anti-inflammatory effects, and induction of apoptosis. It also may be a therapeutic agent against Parkinson's disease. Experiments on animal have shown the sepsis healing therapeutic potential of carnosine.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Monocarboxylate transporters and lactate metabolism in equine athletes: a review. | 2002 |
|
| Efficacy of N-acetylcarnosine in the treatment of cataracts. | 2002 |
|
| Zinc suppresses IL-6 synthesis by prostaglandin F2alpha in osteoblasts: inhibition of phospholipase C and phospholipase D. | 2002 |
|
| High level of skeletal muscle carnosine contributes to the latter half of exercise performance during 30-s maximal cycle ergometer sprinting. | 2002 Apr |
|
| Olfactory neuroepithelioma in a dog: an immunohistochemical and electron microscopic study. | 2002 Apr |
|
| Increase of gamma-glutamyl-beta-alanyl-histidine isopeptide in the macromolecular fraction of model chicken extract during heating and distribution in commercial chicken extracts. | 2002 Apr |
|
| Reaction of carnosine with aged proteins: another protective process? | 2002 Apr |
|
| Induction of a 72-kDa heat-shock protein in cultured rat gastric mucosal cells and rat gastric mucosa by zinc L-carnosine. | 2002 Dec |
|
| Detoxification of cytotoxic alpha,beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle. | 2002 Dec |
|
| Polaprezinc attenuates Helicobacter pylori-associated gastritis in Mongolian gerbils. | 2002 Dec |
|
| tan and ebony genes regulate a novel pathway for transmitter metabolism at fly photoreceptor terminals. | 2002 Dec 15 |
|
| Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products. | 2002 Dec 27 |
|
| The botanical extracts of Achyrocline satureoides and Ilex paraguariensis prevent methylglyoxal-induced inhibition of plasminogen and antithrombin III. | 2002 Dec 6 |
|
| Protective effect of Biolan during ischemic damages to cultured cerebellar granular cells. | 2002 Feb |
|
| Effect of zinc-carnosine chelate compound on muscle function in mdx mouse. | 2002 Feb |
|
| [Polaprezinc]. | 2002 Feb |
|
| [Chaperon-induction therapy for peptic ulcers]. | 2002 Feb |
|
| [New therapeutic approaches to peptic ulcer using mucosal protective agents]. | 2002 Feb |
|
| Carnosine modifies the incidence of genetically abnormal sex cells in the testes of senescence-accelerated mice. | 2002 Jul |
|
| The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro. | 2002 Jul |
|
| Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats. | 2002 Jul 19 |
|
| Could carnosine be a naturally-occurring scavenger for acrolein and other reactive aldehydes in the brain? | 2002 Jul-Aug |
|
| Effect of carnosine on Drosophila melanogaster lifespan. | 2002 Jun |
|
| Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. | 2002 Jun |
|
| Enhanced delivery of drugs to the liver by adenovirus-mediated heterologous expression of the human oligopeptide transporter PEPT1. | 2002 Jun |
|
| Carnosine and related dipeptides protect human ceruloplasmin against peroxyl radical-mediated modification. | 2002 Jun 30 |
|
| [Efficacy and safety of polaprezinc as a preventive drug for radiation-induced stomatitis]. | 2002 Mar |
|
| Effects of thermal denaturation on protein glycation. | 2002 Mar 1 |
|
| Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu,Zn-superoxide dismutase modification. | 2002 Mar 15 |
|
| [Do the glutamate excitotoxicity theory and potential free radicals implication in schizophrenia aetiopathogenesis provide a new enlightenment to links between: genome, environment and biology in the determinism of that disorder?]. | 2002 Mar-Apr |
|
| Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. | 2002 May 15 |
|
| Effects of L-carnosine on renal sympathetic nerve activity and DOCA-salt hypertension in rats. | 2002 May 31 |
|
| Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. | 2002 Nov |
|
| Inhibitory effect of polaprezinc on the inflammatory response to Helicobacter pylori. | 2002 Nov |
|
| Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction? | 2002 Nov 15 |
|
| Antioxidant properties of carnosine re-evaluated in a ferrylmyoglobin model system and in cooked pork patties. | 2002 Nov 20 |
|
| Induction of the estrogen effect-switching phenomenon by ethanol and its correction. | 2002 Nov-Dec |
|
| Effect of zinc-carnosine complex on muscular function in frail distrophin-deficient (mdx) mice. | 2002 Oct |
|
| Plasma carnosine concentration: diurnal variation and effects of age, exercise and muscle damage. | 2002 Sep |
|
| Transport characteristics of L-carnosine and the anticancer derivative 4-toluenesulfonylureido-carnosine in a human epithelial cell line. | 2002 Sep |
|
| Development of a new assay for the screening of hypochlorous acid scavengers based on reversed-phase high-performance liquid chromatography. | 2002 Sep |
|
| Two broad-specificity dipeptide hydrolysing activities from cytoplasm of guinea pig brain, both of which contain prolinase but neither of which contain carnosinase activity. | 2002 Sep |
|
| Involvement of reactive oxygen species in cardiac preconditioning in rats. | 2003 Feb |
|
| RSD931, a novel anti-tussive agent acting on airway sensory nerves. | 2003 Feb |
|
| The carnosine C-2 proton's chemical shift reports intracellular pH in oxidative and glycolytic muscle fibers. | 2003 Feb |
|
| Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. | 2003 Feb 21 |
|
| Ultraviolet spectrophotometric characterization of copper(II) complexes with imidazole N-methyl derivatives of L-histidine in aqueous solution. | 2003 Jan 1 |
|
| Carnosine promotes the heat denaturation of glycated protein. | 2003 Jan 3 |
|
| A practical method to study functional impairment of proteins by glycation and effects of inhibitors using current coagulation/fibrinolysis reagent kits. | 2003 Mar |
|
| Antioxidant peptides with Angiotensin converting enzyme inhibitory activities and applications for Angiotensin converting enzyme purification. | 2003 Mar 12 |
Patents
Sample Use Guides
in rat liver carcinogenesis: carnosine (10mg/kg/day, i.p.) for 2 weeks.
protective effect of carnosine on acute lung injury in sepsis rats: 25 mg/kg and 50 mg/kg, were administered for 30 consecutive days
Route of Administration:
Other
It was studied the anti-carcinogenic effect of L-carnosine in human carcinoma cells (SNU-423). The SNU-423 cancer cells were cultured at a density of 2 × 104 cells/well in Dulbecco modified Eagle medium. After 24 h of adherence, the cells were treated with L-carnosine (0.2 and 1 mg/mL) for 48 h. L-Carnosine significantly inhibited the growth of the SNU-423 cells (p < 0.05). The relative fluorescent unit was increased in a dose-dependent manner by L-carnosine, with values of 79.43, 186.87 and 400.89 for 0.6, 0.8 and 1 mg/mL of L-carnosine, respectively (p < 0.05).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 00:39:34 GMT 2023
by
admin
on
Sat Dec 16 00:39:34 GMT 2023
|
| Record UNII |
5II09M0I3L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
71586822
Created by
admin on Sat Dec 16 00:39:34 GMT 2023 , Edited by admin on Sat Dec 16 00:39:34 GMT 2023
|
PRIMARY | |||
|
DBSALT002049
Created by
admin on Sat Dec 16 00:39:34 GMT 2023 , Edited by admin on Sat Dec 16 00:39:34 GMT 2023
|
PRIMARY | |||
|
1370593
Created by
admin on Sat Dec 16 00:39:34 GMT 2023 , Edited by admin on Sat Dec 16 00:39:34 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID40207238
Created by
admin on Sat Dec 16 00:39:34 GMT 2023 , Edited by admin on Sat Dec 16 00:39:34 GMT 2023
|
PRIMARY | |||
|
5II09M0I3L
Created by
admin on Sat Dec 16 00:39:34 GMT 2023 , Edited by admin on Sat Dec 16 00:39:34 GMT 2023
|
PRIMARY | |||
|
5852-99-3
Created by
admin on Sat Dec 16 00:39:34 GMT 2023 , Edited by admin on Sat Dec 16 00:39:34 GMT 2023
|
PRIMARY | |||
|
m3121
Created by
admin on Sat Dec 16 00:39:34 GMT 2023 , Edited by admin on Sat Dec 16 00:39:34 GMT 2023
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
